Treatment of parkinsonism: the role of DOPA decarboxylase inhibitors
Gespeichert in:
| Weitere Verfasser: | |
|---|---|
| Format: | Buch |
| Sprache: | English |
| Veröffentlicht: |
New York [u.a.]
Raven Press [u.a.]
1973
|
| Schriftenreihe: | Advances in neurology
2 |
| Schlagworte: | |
| Beschreibung: | XIV, 303 S. Ill., graph. Darst. |
| ISBN: | 0911216472 |
Internformat
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV000937991 | ||
| 003 | DE-604 | ||
| 005 | 20150123 | ||
| 007 | t | ||
| 008 | 890315s1973 ad|| |||| 00||| eng d | ||
| 020 | |a 0911216472 |9 0-911216-47-2 | ||
| 035 | |a (OCoLC)663208 | ||
| 035 | |a (DE-599)BVBBV000937991 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-19 |a DE-355 |a DE-20 |a DE-578 |a DE-11 | ||
| 050 | 0 | |a RC382 | |
| 082 | 0 | |a 616.8/33/061 | |
| 084 | |a YG 5515 |0 (DE-625)153506:12921 |2 rvk | ||
| 245 | 1 | 0 | |a Treatment of parkinsonism |b the role of DOPA decarboxylase inhibitors |c ed. by Melvin D. Yahr |
| 264 | 1 | |a New York [u.a.] |b Raven Press [u.a.] |c 1973 | |
| 300 | |a XIV, 303 S. |b Ill., graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a Advances in neurology |v 2 | |
| 650 | 4 | |a Antienzymes - Congrès | |
| 650 | 4 | |a DOPA-décarboxylase - Congrès | |
| 650 | 4 | |a Parkinson, Maladie de - Congrès | |
| 650 | 4 | |a Aromatic amino acid decarboxylases |x Inhibitors |x Therapeutic use |v Congresses | |
| 650 | 4 | |a Aromatic-L-Amino-Acid Decarboxylases |x antagonists & inhibitors |v Congresses | |
| 650 | 4 | |a Dihydroxyphenylalanine |x pharmacology |v Congresses | |
| 650 | 4 | |a Dihydroxyphenylalanine |x therapeutic use |v Congresses | |
| 650 | 4 | |a Enzyme inhibitors |v Congresses | |
| 650 | 4 | |a Parkinson Disease |x drug therapy |v Congresses | |
| 650 | 4 | |a Parkinson's disease |v Congresses | |
| 650 | 0 | 7 | |a Behandlung |0 (DE-588)4144322-6 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Parkinsonismus |0 (DE-588)4173363-0 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |2 gnd-content | |
| 689 | 0 | 0 | |a Parkinsonismus |0 (DE-588)4173363-0 |D s |
| 689 | 0 | 1 | |a Behandlung |0 (DE-588)4144322-6 |D s |
| 689 | 0 | |5 DE-604 | |
| 700 | 1 | |a Yahr, Melvin D. |d 1917-2004 |0 (DE-588)172468299 |4 edt | |
| 830 | 0 | |a Advances in neurology |v 2 |w (DE-604)BV000000622 |9 2 | |
| 940 | 1 | |q HUB-ZB011201202 | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-000573826 | ||
Datensatz im Suchindex
| _version_ | 1804115370027515904 |
|---|---|
| any_adam_object | |
| author2 | Yahr, Melvin D. 1917-2004 |
| author2_role | edt |
| author2_variant | m d y md mdy |
| author_GND | (DE-588)172468299 |
| author_facet | Yahr, Melvin D. 1917-2004 |
| building | Verbundindex |
| bvnumber | BV000937991 |
| callnumber-first | R - Medicine |
| callnumber-label | RC382 |
| callnumber-raw | RC382 |
| callnumber-search | RC382 |
| callnumber-sort | RC 3382 |
| callnumber-subject | RC - Internal Medicine |
| classification_rvk | YG 5515 |
| ctrlnum | (OCoLC)663208 (DE-599)BVBBV000937991 |
| dewey-full | 616.8/33/061 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.8/33/061 |
| dewey-search | 616.8/33/061 |
| dewey-sort | 3616.8 233 261 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01972nam a2200517 cb4500</leader><controlfield tag="001">BV000937991</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20150123 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">890315s1973 ad|| |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0911216472</subfield><subfield code="9">0-911216-47-2</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)663208</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV000937991</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-19</subfield><subfield code="a">DE-355</subfield><subfield code="a">DE-20</subfield><subfield code="a">DE-578</subfield><subfield code="a">DE-11</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC382</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.8/33/061</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">YG 5515</subfield><subfield code="0">(DE-625)153506:12921</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Treatment of parkinsonism</subfield><subfield code="b">the role of DOPA decarboxylase inhibitors</subfield><subfield code="c">ed. by Melvin D. Yahr</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York [u.a.]</subfield><subfield code="b">Raven Press [u.a.]</subfield><subfield code="c">1973</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XIV, 303 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Advances in neurology</subfield><subfield code="v">2</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antienzymes - Congrès</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">DOPA-décarboxylase - Congrès</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Parkinson, Maladie de - Congrès</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Aromatic amino acid decarboxylases</subfield><subfield code="x">Inhibitors</subfield><subfield code="x">Therapeutic use</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Aromatic-L-Amino-Acid Decarboxylases</subfield><subfield code="x">antagonists & inhibitors</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Dihydroxyphenylalanine</subfield><subfield code="x">pharmacology</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Dihydroxyphenylalanine</subfield><subfield code="x">therapeutic use</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Enzyme inhibitors</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Parkinson Disease</subfield><subfield code="x">drug therapy</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Parkinson's disease</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Behandlung</subfield><subfield code="0">(DE-588)4144322-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Parkinsonismus</subfield><subfield code="0">(DE-588)4173363-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Parkinsonismus</subfield><subfield code="0">(DE-588)4173363-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Behandlung</subfield><subfield code="0">(DE-588)4144322-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Yahr, Melvin D.</subfield><subfield code="d">1917-2004</subfield><subfield code="0">(DE-588)172468299</subfield><subfield code="4">edt</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Advances in neurology</subfield><subfield code="v">2</subfield><subfield code="w">(DE-604)BV000000622</subfield><subfield code="9">2</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">HUB-ZB011201202</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-000573826</subfield></datafield></record></collection> |
| genre | (DE-588)1071861417 Konferenzschrift gnd-content |
| genre_facet | Konferenzschrift |
| id | DE-604.BV000937991 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T15:21:32Z |
| institution | BVB |
| isbn | 0911216472 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-000573826 |
| oclc_num | 663208 |
| open_access_boolean | |
| owner | DE-19 DE-BY-UBM DE-355 DE-BY-UBR DE-20 DE-578 DE-11 |
| owner_facet | DE-19 DE-BY-UBM DE-355 DE-BY-UBR DE-20 DE-578 DE-11 |
| physical | XIV, 303 S. Ill., graph. Darst. |
| psigel | HUB-ZB011201202 |
| publishDate | 1973 |
| publishDateSearch | 1973 |
| publishDateSort | 1973 |
| publisher | Raven Press [u.a.] |
| record_format | marc |
| series | Advances in neurology |
| series2 | Advances in neurology |
| spelling | Treatment of parkinsonism the role of DOPA decarboxylase inhibitors ed. by Melvin D. Yahr New York [u.a.] Raven Press [u.a.] 1973 XIV, 303 S. Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier Advances in neurology 2 Antienzymes - Congrès DOPA-décarboxylase - Congrès Parkinson, Maladie de - Congrès Aromatic amino acid decarboxylases Inhibitors Therapeutic use Congresses Aromatic-L-Amino-Acid Decarboxylases antagonists & inhibitors Congresses Dihydroxyphenylalanine pharmacology Congresses Dihydroxyphenylalanine therapeutic use Congresses Enzyme inhibitors Congresses Parkinson Disease drug therapy Congresses Parkinson's disease Congresses Behandlung (DE-588)4144322-6 gnd rswk-swf Parkinsonismus (DE-588)4173363-0 gnd rswk-swf (DE-588)1071861417 Konferenzschrift gnd-content Parkinsonismus (DE-588)4173363-0 s Behandlung (DE-588)4144322-6 s DE-604 Yahr, Melvin D. 1917-2004 (DE-588)172468299 edt Advances in neurology 2 (DE-604)BV000000622 2 |
| spellingShingle | Treatment of parkinsonism the role of DOPA decarboxylase inhibitors Advances in neurology Antienzymes - Congrès DOPA-décarboxylase - Congrès Parkinson, Maladie de - Congrès Aromatic amino acid decarboxylases Inhibitors Therapeutic use Congresses Aromatic-L-Amino-Acid Decarboxylases antagonists & inhibitors Congresses Dihydroxyphenylalanine pharmacology Congresses Dihydroxyphenylalanine therapeutic use Congresses Enzyme inhibitors Congresses Parkinson Disease drug therapy Congresses Parkinson's disease Congresses Behandlung (DE-588)4144322-6 gnd Parkinsonismus (DE-588)4173363-0 gnd |
| subject_GND | (DE-588)4144322-6 (DE-588)4173363-0 (DE-588)1071861417 |
| title | Treatment of parkinsonism the role of DOPA decarboxylase inhibitors |
| title_auth | Treatment of parkinsonism the role of DOPA decarboxylase inhibitors |
| title_exact_search | Treatment of parkinsonism the role of DOPA decarboxylase inhibitors |
| title_full | Treatment of parkinsonism the role of DOPA decarboxylase inhibitors ed. by Melvin D. Yahr |
| title_fullStr | Treatment of parkinsonism the role of DOPA decarboxylase inhibitors ed. by Melvin D. Yahr |
| title_full_unstemmed | Treatment of parkinsonism the role of DOPA decarboxylase inhibitors ed. by Melvin D. Yahr |
| title_short | Treatment of parkinsonism |
| title_sort | treatment of parkinsonism the role of dopa decarboxylase inhibitors |
| title_sub | the role of DOPA decarboxylase inhibitors |
| topic | Antienzymes - Congrès DOPA-décarboxylase - Congrès Parkinson, Maladie de - Congrès Aromatic amino acid decarboxylases Inhibitors Therapeutic use Congresses Aromatic-L-Amino-Acid Decarboxylases antagonists & inhibitors Congresses Dihydroxyphenylalanine pharmacology Congresses Dihydroxyphenylalanine therapeutic use Congresses Enzyme inhibitors Congresses Parkinson Disease drug therapy Congresses Parkinson's disease Congresses Behandlung (DE-588)4144322-6 gnd Parkinsonismus (DE-588)4173363-0 gnd |
| topic_facet | Antienzymes - Congrès DOPA-décarboxylase - Congrès Parkinson, Maladie de - Congrès Aromatic amino acid decarboxylases Inhibitors Therapeutic use Congresses Aromatic-L-Amino-Acid Decarboxylases antagonists & inhibitors Congresses Dihydroxyphenylalanine pharmacology Congresses Dihydroxyphenylalanine therapeutic use Congresses Enzyme inhibitors Congresses Parkinson Disease drug therapy Congresses Parkinson's disease Congresses Behandlung Parkinsonismus Konferenzschrift |
| volume_link | (DE-604)BV000000622 |
| work_keys_str_mv | AT yahrmelvind treatmentofparkinsonismtheroleofdopadecarboxylaseinhibitors |